Fatima Karzai

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.518Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae018

Top 37%

0.518DataRank

Top 37%13 citations

Fatima Karzai, Ryan David Nipp, Abdul Rafeh Naqash, James L. Gulley, Charalampos S. Floudas +1 more

Papers

Driven by 71 papers — median percentile 63. Top paper: “Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies”.

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001395

N/A

3.6DataRank · unranked

159 citations

Margaret E. Gatti‐Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward F. McClay +18 more

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000655

N/A

1.8DataRank · unranked

77 citations

Jennifer L. Marté, Renee N. Donahue, Beatriz Walter-Rodriguez, Christopher R. Heery, Seth M. Steinberg +13 more

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2344

N/A

1.2DataRank · unranked

38 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003238

N/A

1.2DataRank · unranked

41 citations

Katherine Lee-Wisdom, Renee N. Donahue, Ravi A. Madan, Fatima Karzai, Angie Schwab +16 more

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00492-y

N/A

0.873DataRank · unranked

22 citations

Nicole J. Toney, Renee N. Donahue, Susan Wróblewski, Matthew R. Zibelman, Pooja Ghatalia +9 more

A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide

The Oncologist(2022)10.1093/oncolo/oyac100

N/A

0.790DataRank · unranked

24 citations

Fatima Karzai, Marijo Bilušić, Lisa M. Cordes, Cindy H. Chau, Cody J. Peer +8 more

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyac244

N/A

0.588DataRank · unranked

16 citations

Nicholas Tschernia, Julius Strauss, Ravi A. Madan, Fatima Karzai, Marijo Bilušić +14 more

Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae018

Top 37%

0.518DataRank

Top 37%13 citations

Fatima Karzai, Ryan David Nipp, Abdul Rafeh Naqash, James L. Gulley, Charalampos S. Floudas +1 more

Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine

Journal of Immunotherapy(2023)10.1097/cji.0000000000000459

N/A

0.261DataRank · unranked

4 citations

Jason M. Redman, Fatima Karzai, William L. Dahut, Lisa M. Cordes, Farhad Fakhrejahani +5 more

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1553

N/A

0.188DataRank · unranked

2 citations

Gal Dinstag, Eldad D. Shulman, Efrat Elis, Doreen S. Ben-Zvi, Omer Tirosh +15 more

Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition

Journal of Clinical Investigation(2025)10.1172/jci189900

N/A

0.172DataRank · unranked

2 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +26 more

Multiple primary prostate tumors with differential drug sensitivity.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.342

N/A

0DataRank · unranked

0 citations

Huihui Ye, Nicholas T. Terrigino, Nicole V. Carrabba, Rayann Atway, Shana Y. Trostel +14 more

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

European Urology(2021)10.1016/j.eururo.2021.03.009

N/A

0DataRank · unranked

74 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.581801

N/A

0DataRank · unranked

22 citations

Sofia R. Gameiro, Yohei Ozawa, Karin M. Knudson, Kristin C. Hicks, Claudia Palena +10 more

Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.05.005

N/A

0DataRank · unranked

3 citations

Ravi A. Madan, Marijo Bilušić, Helen Owens, Lisa M. Cordes, Jennifer L. Marté +5 more

Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2501

N/A

0DataRank · unranked

20 citations

Charalampos S. Floudas, Houssein Abdul Sater, Michell Manu, Elizabeth Lamping, Deneise C Francis +15 more

A phase I/II study of bintrafusp alfa and NHS-IL12 in combination with docetaxel in adults with metastatic castration sensitive (mCSPC) and castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps5096

N/A

0DataRank · unranked

3 citations

Marijo Bilušić, Fatima Karzai, Lisa M. Cordes, Julius Strauss, Houssein Abdul Sater +10 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

Patients with undetectable PSA 2 years after docetaxel for metastatic castration sensitive prostate cancer (mCSPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17044

N/A

0DataRank · unranked

1 citations

Shruti U. Gandhy, Fatima Karzai, Marijo Bilušić, Lisa M. Cordes, Helen Owens +8 more

Anaplastic features (AnaF) and DNA-damage repair pathway (DDR) mutations in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.92

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Marijo Bilušić, Lisa M. Cordes, Jennifer L. Marté, Helen Owens +6 more

A phase 1 open label trial of intravenous administration of MVA-BN-Brachyury vaccine in patients with advanced cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2617

N/A

0DataRank · unranked

0 citations

Katherine Lee-Wisdom, Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Claudia Palena +14 more

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

Med(2022)10.1016/j.medj.2022.11.001

N/A

0DataRank · unranked

42 citations

Eldad D. Shulman, Efrat Elis, Doreen S. Ben-Zvi, Omer Tirosh, Eden Maimon +26 more

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0851

N/A

0DataRank · unranked

32 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute

The Cancer Journal(2022)10.1097/ppo.0000000000000584

N/A

0DataRank · unranked

6 citations

William L. Dahut, Fatima Karzai

Deciphering the enigma of neuroendocrine prostate cancer

Journal of Clinical Investigation(2022)10.1172/jci164611

N/A

0DataRank · unranked

6 citations

Ravi A. Madan, Fatima Karzai

Phase II evaluation of the combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2518

N/A

0DataRank · unranked

11 citations

Charalampos S. Floudas, Danielle M. Pastor, Michell Manu, Elizabeth Lamping, Deneise C Francis +11 more

The immunocytokine M9241 in the treatment of prostate cancer (PCa): Clinical and immune data from a phase 1 study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.127

N/A

0DataRank · unranked

4 citations

Ravi A. Madan, Nicole J. Toney, Renee N. Donahue, Margaret E. Gatti‐Mays, Julius Strauss +12 more

Safety evaluation of M9241 in combination with docetaxel in metastatic prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.093

N/A

0DataRank · unranked

4 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Evaluating the optimal sequence of immunotherapy and docetaxel in men with metastatic castration-sensitive prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.130

N/A

0DataRank · unranked

3 citations

Mohammad Atiq, Renee N. Donahue, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +11 more

The origin and dynamics of cellular heterogeneity vary across lineage subtypes of castrate resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.24.484651

N/A

0DataRank · unranked

3 citations

Brian J. Capaldo, Ross Lake, Anson T. Ku, Danielle Burner, Caitlin M. Tice +12 more

Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17033

N/A

0DataRank · unranked

3 citations

Elias Bin Aris Chandran, Luke Meininger, Fatima Karzai, Marijo Bilušić, Jennifer L. Marté +15 more

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

medRxiv(2022)10.1101/2022.03.10.22271799

N/A

0DataRank · unranked

2 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

PSMA PET findings in patients with undetectable PSA more than 3 years after docetaxel for metastatic castration-sensitive prostate cancer (mCSPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e17046

N/A

0DataRank · unranked

1 citations

Shruti U. Gandhy, Fatima Karzai, Munjid Al Harthy, Gang Chen, Marijo Bilušić +15 more

Applications of large language models in cancer care: current evidence and future perspectives

Frontiers in Oncology(2023)10.3389/fonc.2023.1268915

N/A

0DataRank · unranked

114 citations

Dara Bracken‐Clarke, Charalampos S. Floudas, Mario Roselli, James L. Gulley, Fatima Karzai +1 more

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials

Cancer Treatment Reviews(2023)10.1016/j.ctrv.2023.102623

N/A

0DataRank · unranked

37 citations

Elias Chandran, Charalampos S. Floudas, Hyoyoung Choo‐Wosoba, Gisela Butera, Mario Roselli +3 more

Emerging treatment options for prostate cancer

Expert Review of Anticancer Therapy(2023)10.1080/14737140.2023.2208352

N/A

0DataRank · unranked

19 citations

Elias Chandran, Fatima Karzai, Ravi A. Madan, Jeanny B. Aragon‐Ching, Mohammad Atiq

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report

Frontiers in Oncology(2023)10.3389/fonc.2023.1126476

N/A

0DataRank · unranked

1 citations

Danielle M. Pastor, Fatima Karzai, Amy Hankin, Barış Türkbey, Lisa M. Cordes +5 more

Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide

European Urology Oncology(2023)10.1016/j.euo.2023.09.010

N/A

0DataRank · unranked

3 citations

Fatima Karzai, Marijo Bilušić, Sheri McMahon, Lisa M. Cordes, Jennifer L. Marté +12 more

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

medRxiv(2023)10.1101/2023.10.31.23297825

N/A

0DataRank · unranked

9 citations

Dara Bracken‐Clarke, Fatima Karzai, Hyoyoung Choo‐Wosoba, James L. Gulley, Charalampos S. Floudas +1 more

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.377

N/A

0DataRank · unranked

1 citations

Nicole J. Toney, Renee N. Donahue, Fatima Karzai, Ravi A. Madan, Jeffrey Schlom +8 more

Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.390

N/A

0DataRank · unranked

1 citations

Barış Türkbey, Peter L. Choyke, Katherine Lee-Wisdom, Yolanda McKinney, Robert Sidlow +10 more

Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.207

N/A

0DataRank · unranked

0 citations

Meghali Goswami, Renee N. Donahue, Mohammad Atiq, Fatima Karzai, Marijo Bilušić +13 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054.v1

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

(2023)10.1158/1078-0432.c.6532445

N/A

0DataRank · unranked

0 citations

Ines Figueiredo, Rosina T. Lis, Ilsa M. Coleman, Bora Gurel, Denisa Bogdan +26 more

A multi-center natural history study of precision-based genomics in prostate cancer (PC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5121

N/A

0DataRank · unranked

0 citations

Joaquı́n Mateo, Wassim Abida, Rana R. McKay, Bruce Montgomery, Rahul Aggarwal +5 more

A study of prospective monitoring of patients with recurrent prostate cancer using serial PSMA imaging (18F-DCFPyL).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5101

N/A

0DataRank · unranked

0 citations

Liza Lindenberg, Esther Mena Gonzalez, Barış Türkbey, Fatima Karzai, Megan Hausler +8 more

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

The Oncologist(2024)10.1093/oncolo/oyae009

N/A

0DataRank · unranked

40 citations

Dara Bracken‐Clarke, Fatima Karzai, Hyoyoung Choo‐Wosoba, James L. Gulley, Charalampos S. Floudas +1 more

Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients

Current Opinion in Oncology(2024)10.1097/cco.0000000000001030

N/A

0DataRank · unranked

10 citations

Jeanny B. Aragon‐Ching, Fatima Karzai, Ravi A. Madan, David J. Einstein

Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer

Stem Cells(2024)10.1093/stmcls/sxae025

N/A

0DataRank · unranked

6 citations

Brian J. Capaldo, Ross Lake, Anson T. Ku, Danielle Burner, Caitlin M. Tice +12 more

1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1712

N/A

0DataRank · unranked

3 citations

Ravi A. Madan, Fatima Karzai, Lisa M. Cordes, Jenn Marte, N. Williams +9 more

Enzalutamide Monotherapy in the EMBARK Trial Should Be Practice-changing and Existing Data Suggest How to Mitigate Toxicity

European Urology Oncology(2024)10.1016/j.euo.2024.06.001

N/A

0DataRank · unranked

1 citations

Fatima Karzai, Ravi A. Madan, Lisa M. Cordes

Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care

Journal of Clinical Oncology(2024)10.1200/jco.23.02727

N/A

0DataRank · unranked

5 citations

Evan Y. Yu, Edwin M. Posadas, Richard J. Lee, Fatima Karzai, Peter L. Choyke +1 more

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

medRxiv(2024)10.1101/2024.02.09.24302395

N/A

0DataRank · unranked

4 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +21 more

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009–2023)

European Journal of Cancer(2025)10.1016/j.ejca.2025.115589

N/A

0DataRank · unranked

6 citations

Charalampos S. Floudas, Marco Filetti, Tommaso Giovagnoli, Stefano Sganga, Antonio Vitale +13 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion

Journal of Clinical Investigation(2025)10.1172/jci192368

N/A

0DataRank · unranked

1 citations

Sen Chen, Luigi Cecchi, Betul Ersoy-Fazlioglu, Joshua W. Russo, Seiji Arai +16 more

Radium 223 without androgen deprivation therapy (ADT) in patients (Pts) with biochemically recurrent prostate cancer (BCR) and PET findings in the bones.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.180

N/A

0DataRank · unranked

0 citations

Fatima Karzai, Philip M. Arlen, Clara Chen, Esther Mena, Liza Lindenberg +11 more

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial

The Prostate(2025)10.1002/pros.70093

N/A

0DataRank · unranked

0 citations

Nikhil Pramod, Rubén Blachman-Braun, Jaskirat Saini, Lauren Loebach, Milan Patel +5 more

A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancer

The Oncologist(2025)10.1093/oncolo/oyaf429

N/A

0DataRank · unranked

0 citations

Renee N. Donahue, Jennifer L. Marté, Ann Gramza, Marijo Bilušić, Lisa M. Cordes +5 more

Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.11.002

N/A

0DataRank · unranked

17 citations

Keith T. Schmidt, Fatima Karzai, Cody J. Peer, Lisa M. Cordes, Cindy H. Chau +8 more

Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer

British Journal of Urology(2020)10.1111/bju.15227

N/A

0DataRank · unranked

13 citations

Fatima Karzai, Munjid Al Harthy, Daniel P. Petrylak, Joseph W. Kim, Philip M. Arlen +22 more

The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer

Urologic Clinics of North America(2020)10.1016/j.ucl.2020.07.004

N/A

0DataRank · unranked

11 citations

David J. Einstein, Fatima Karzai, William L. Dahut, James L. Gulley, Jeanny B. Aragon‐Ching +2 more

A case report of multiple primary prostate tumors with differential drug sensitivity

Nature Communications(2020)10.1038/s41467-020-14657-7

N/A

0DataRank · unranked

40 citations

Stephanie A. Harmon, Nicholas T. Terrigino, Fatima Karzai, Peter A. Pinto, Ravi A. Madan +16 more

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

medRxiv(2020)10.1101/2020.09.29.20199711

N/A

0DataRank · unranked

12 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.105

N/A

0DataRank · unranked

7 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +10 more

Artificial intelligence assisted bone lesion detection and classification in computed tomography scans of prostate cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17567

N/A

0DataRank · unranked

4 citations

Sherif Mehralivand, Stephanie A. Harmon, Stephanie M. Walker, Peter A. Pinto, Bradford J. Wood +8 more

Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17569

N/A

0DataRank · unranked

1 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +13 more

Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.85

N/A

0DataRank · unranked

0 citations

Matthew R. Zibelman, Pooja Ghatalia, Susan Wróblewski, Ravi A. Madan, Fatima Karzai +5 more

A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.368

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Adam G. Sowalsky, Marijo Bilušić, Guinevere Chun, Lisa M. Cordes +9 more

Fatima Karzai

Indexed papers

Top data-sharing exemplar

Papers